JP2019131544A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019131544A5 JP2019131544A5 JP2019013745A JP2019013745A JP2019131544A5 JP 2019131544 A5 JP2019131544 A5 JP 2019131544A5 JP 2019013745 A JP2019013745 A JP 2019013745A JP 2019013745 A JP2019013745 A JP 2019013745A JP 2019131544 A5 JP2019131544 A5 JP 2019131544A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- formula
- acceptable salt
- diabetes
- compound represented
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023034806A JP2023071925A (ja) | 2018-02-01 | 2023-03-07 | 含窒素複素環アミド化合物及びその医薬用途 |
| JP2024094812A JP2024116307A (ja) | 2018-02-01 | 2024-06-12 | 含窒素複素環アミド化合物及びその医薬用途 |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2018016328 | 2018-02-01 | ||
| JP2018016328 | 2018-02-01 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023034806A Division JP2023071925A (ja) | 2018-02-01 | 2023-03-07 | 含窒素複素環アミド化合物及びその医薬用途 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019131544A JP2019131544A (ja) | 2019-08-08 |
| JP2019131544A5 true JP2019131544A5 (enExample) | 2022-02-03 |
| JP7241556B2 JP7241556B2 (ja) | 2023-03-17 |
Family
ID=67479787
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019013745A Active JP7241556B2 (ja) | 2018-02-01 | 2019-01-30 | 含窒素複素環アミド化合物及びその医薬用途 |
| JP2023034806A Ceased JP2023071925A (ja) | 2018-02-01 | 2023-03-07 | 含窒素複素環アミド化合物及びその医薬用途 |
| JP2024094812A Ceased JP2024116307A (ja) | 2018-02-01 | 2024-06-12 | 含窒素複素環アミド化合物及びその医薬用途 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023034806A Ceased JP2023071925A (ja) | 2018-02-01 | 2023-03-07 | 含窒素複素環アミド化合物及びその医薬用途 |
| JP2024094812A Ceased JP2024116307A (ja) | 2018-02-01 | 2024-06-12 | 含窒素複素環アミド化合物及びその医薬用途 |
Country Status (21)
| Country | Link |
|---|---|
| US (4) | US10800784B2 (enExample) |
| EP (1) | EP3747888A4 (enExample) |
| JP (3) | JP7241556B2 (enExample) |
| KR (1) | KR102725118B1 (enExample) |
| CN (1) | CN111655692B (enExample) |
| AR (1) | AR114237A1 (enExample) |
| AU (1) | AU2019214048B2 (enExample) |
| BR (1) | BR112020014177A2 (enExample) |
| CA (1) | CA3090219A1 (enExample) |
| CL (1) | CL2020002003A1 (enExample) |
| CO (1) | CO2020009420A2 (enExample) |
| IL (1) | IL276386B2 (enExample) |
| MX (1) | MX2020008126A (enExample) |
| MY (1) | MY205011A (enExample) |
| PE (1) | PE20211273A1 (enExample) |
| PH (1) | PH12020500613A1 (enExample) |
| SA (1) | SA520412473B1 (enExample) |
| SG (1) | SG11202006916SA (enExample) |
| TW (1) | TWI803570B (enExample) |
| WO (1) | WO2019151274A1 (enExample) |
| ZA (1) | ZA202004548B (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3851103A4 (en) | 2018-09-11 | 2022-06-08 | Japan Tobacco Inc. | THERAPEUTIC OR PROPHYLACTIC AGENT FOR CHRONIC KIDNEY DISEASE CONTAINING A PYRAZOLE-AMIDE COMPOUND |
| WO2023032940A1 (ja) | 2021-09-01 | 2023-03-09 | 日本たばこ産業株式会社 | 含窒素三環性化合物及びその医薬用途 |
| CN110407744A (zh) * | 2019-08-13 | 2019-11-05 | 上海毕得医药科技有限公司 | 一种1-(4-氨基吡啶-2-基)乙酮的合成方法 |
| PT4097099T (pt) | 2020-02-07 | 2024-07-19 | Gasherbrum Bio Inc | Agonistas heterocíclicos de glp-1 |
| BR112022014749A2 (pt) * | 2020-03-04 | 2022-10-11 | Japan Tobacco Inc | Composto tricíclico fundido e uso medicinal do mesmo |
| WO2022052958A1 (en) * | 2020-09-10 | 2022-03-17 | Gasherbrum Bio, Inc. | Heterocyclic glp-1 agonists |
| AU2022244941B2 (en) * | 2021-03-23 | 2024-08-01 | Shanghai Haiyan Pharmaceutical Technology Co., Ltd. | Heterocycle substituted ketone derivative, and composition and medicinal use thereof |
| KR20250168210A (ko) | 2023-02-16 | 2025-12-02 | 가셔브룸 바이오, 인크. | 헤테로시클릭 glp-1 효능제 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7943617B2 (en) * | 2006-11-27 | 2011-05-17 | Bristol-Myers Squibb Company | Heterobicyclic compounds useful as kinase inhibitors |
| WO2008132162A1 (en) * | 2007-04-26 | 2008-11-06 | Boehringer Ingelheim International Gmbh | 3- (sulphonylamino) -phenyl-2 -hydroxy-ethylamino derivatives useful as beta-agonists, processes for preparing them and their use as medicaments |
| AU2008263206A1 (en) * | 2007-06-01 | 2008-12-18 | Schering Corporation | Gamma secretase modulators |
| EP2090576A1 (en) * | 2008-02-01 | 2009-08-19 | Merz Pharma GmbH & Co.KGaA | 6-halo-pyrazolo[1,5-a]pyridines, a process for their preparation and their use as metabotropic glutamate receptor (mGluR) modulators |
| AR074797A1 (es) * | 2008-10-10 | 2011-02-16 | Japan Tobacco Inc | Compuesto de fluoreno , composiciones farmaceuticas , inhibidores de pdhk y pdhk2 , metodos de tratamiento , usos de los mismos y kit comercial |
| MX364602B (es) * | 2011-06-27 | 2019-05-02 | Alectos Therapeutics Inc | Inhibidores selectivos de glicosidasa y usos de los mismos. |
| CA2855009C (en) * | 2011-11-15 | 2019-07-09 | Merck Sharp & Dohme Corp. | Substituted cyclopropyl compounds useful as gpr119 agonists |
| WO2013187646A1 (en) * | 2012-06-12 | 2013-12-19 | Chong Kun Dang Pharmaceutical Corp. | Piperidine derivatives for gpr119 agonist |
| CN103570725B (zh) | 2012-08-01 | 2017-03-22 | 中国科学院上海药物研究所 | 哌嗪并三唑类化合物及其制备方法和用途 |
| TWI633885B (zh) * | 2013-03-15 | 2018-09-01 | 日商日本煙草產業股份有限公司 | 吡唑－醯胺化合物及其醫藥用途 |
| TW201536748A (zh) * | 2013-07-01 | 2015-10-01 | Japan Tobacco Inc | 茀－醯胺化合物及其醫藥用途 |
| WO2015002119A1 (ja) | 2013-07-01 | 2015-01-08 | 日本たばこ産業株式会社 | ピラゾール－アルコール化合物およびその医薬用途 |
| GB201316823D0 (en) * | 2013-09-23 | 2013-11-06 | R & D Vernalis Ltd | New Chemical Entities |
| CA2933927C (en) | 2013-12-17 | 2021-11-16 | Merck Patent Gmbh | N1-(3,3,3-trifluoro-2-hydroxo-2-methylpropionyl)-piperidine derivatives as inhibitors of pyruvate dehydrogenase kinase |
| CA2994027C (en) | 2015-07-31 | 2023-10-10 | Merck Patent Gmbh | Bicyclic heterocyclic derivatives |
| EP3436443B1 (en) | 2016-03-29 | 2020-03-11 | Merck Patent GmbH | N1-(3,3,3-trifluoro-2-hydroxy-2-methylpropionyl)-piperidine derivatives as inhibitors of pyruvate dehydrogenase kinase |
| CN109071490B (zh) * | 2016-04-28 | 2021-04-06 | 默克专利股份公司 | 哌啶基衍生物 |
| EP3492452B1 (en) * | 2016-07-29 | 2022-08-31 | Japan Tobacco Inc. | Production method for pyrazole-amide compound |
| US10414774B2 (en) | 2016-08-15 | 2019-09-17 | Merck Sharp & Dohme Corp. | Compound useful for altering the levels of bile acids for the treatment of diabetes and cardiometabolc disease |
| LT3532064T (lt) | 2016-10-28 | 2020-09-25 | H. Lundbeck A/S | Kompleksiniai gydymai, apimantys imidazopirazonus, skirti psichiatrinių ir (arba) kognityvinių sutrikimų gydymui |
| RU2019108717A (ru) | 2016-10-28 | 2020-11-30 | Х. Лундбекк А/С | Комбинированные средства для лечения, предусматривающего введение имидазопиразинонов |
| WO2023032940A1 (ja) * | 2021-09-01 | 2023-03-09 | 日本たばこ産業株式会社 | 含窒素三環性化合物及びその医薬用途 |
| BR112022014749A2 (pt) * | 2020-03-04 | 2022-10-11 | Japan Tobacco Inc | Composto tricíclico fundido e uso medicinal do mesmo |
-
2019
- 2019-01-30 PE PE2020001125A patent/PE20211273A1/es unknown
- 2019-01-30 EP EP19747660.9A patent/EP3747888A4/en active Pending
- 2019-01-30 KR KR1020207024426A patent/KR102725118B1/ko active Active
- 2019-01-30 MY MYPI2020003575A patent/MY205011A/en unknown
- 2019-01-30 CN CN201980010396.9A patent/CN111655692B/zh active Active
- 2019-01-30 US US16/261,792 patent/US10800784B2/en active Active
- 2019-01-30 AR ARP190100202A patent/AR114237A1/es unknown
- 2019-01-30 CA CA3090219A patent/CA3090219A1/en active Pending
- 2019-01-30 AU AU2019214048A patent/AU2019214048B2/en active Active
- 2019-01-30 SG SG11202006916SA patent/SG11202006916SA/en unknown
- 2019-01-30 TW TW108103504A patent/TWI803570B/zh active
- 2019-01-30 WO PCT/JP2019/003052 patent/WO2019151274A1/ja not_active Ceased
- 2019-01-30 JP JP2019013745A patent/JP7241556B2/ja active Active
- 2019-01-30 MX MX2020008126A patent/MX2020008126A/es unknown
- 2019-01-30 BR BR112020014177-1A patent/BR112020014177A2/pt unknown
-
2020
- 2020-07-14 PH PH12020500613A patent/PH12020500613A1/en unknown
- 2020-07-21 SA SA520412473A patent/SA520412473B1/ar unknown
- 2020-07-22 ZA ZA2020/04548A patent/ZA202004548B/en unknown
- 2020-07-29 IL IL276386A patent/IL276386B2/en unknown
- 2020-07-29 CO CONC2020/0009420A patent/CO2020009420A2/es unknown
- 2020-07-30 CL CL2020002003A patent/CL2020002003A1/es unknown
- 2020-10-08 US US17/065,679 patent/US20210284644A1/en not_active Abandoned
-
2023
- 2023-03-07 JP JP2023034806A patent/JP2023071925A/ja not_active Ceased
- 2023-09-05 US US18/460,821 patent/US20240300952A1/en not_active Abandoned
-
2024
- 2024-06-12 JP JP2024094812A patent/JP2024116307A/ja not_active Ceased
-
2025
- 2025-02-13 US US19/052,425 patent/US20260070910A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021516240A5 (enExample) | ||
| JP2015524443A5 (enExample) | ||
| JP2014518853A5 (enExample) | ||
| JP2023529354A5 (enExample) | ||
| JP2016500063A5 (enExample) | ||
| RU98119885A (ru) | Фармацевтическая композиция, содержащая соединение, имеющее ангиотензин ii антагонистическую активность | |
| JP2017504640A5 (enExample) | ||
| JP2019531320A5 (enExample) | ||
| JP2016512505A5 (enExample) | ||
| JP2020502111A5 (enExample) | ||
| JP2007527919A5 (enExample) | ||
| RU2017110211A (ru) | ИНГИБИТОРЫ α-АМИНО-β-КАРБОКСИМУКОНАТ-ε-СЕМИАЛЬДЕГИД-ДЕКАРБОКСИЛАЗЫ | |
| JP2010516701A5 (enExample) | ||
| RU2015144182A (ru) | Пиразоламидное соединение и его применения в медицине | |
| RU2009128191A (ru) | Замещенные метилфенилкетоны, пригодные для использования в качестве ингибиторов pde4 | |
| JP2018534288A5 (enExample) | ||
| JP2010516702A5 (enExample) | ||
| IL320810A (en) | Glucagon-like peptide 1 receptor agonists | |
| PH12020500613A1 (en) | Nitrogenated heterocyclic amide compound, and use thereof for medical purposes | |
| JP2022537350A5 (enExample) | ||
| JP2020111571A5 (enExample) | ||
| JP2022007994A5 (enExample) | ||
| JP2025512098A5 (enExample) | ||
| JP2012509858A (ja) | 肥大性心筋症治療用のホスホジエステラーゼタイプＩＩＩ（ＰＤＥＩＩＩ）インヒビターまたはＣａ２＋感作剤 | |
| RU2015150614A (ru) | Новые 3, 4-дигидро-2н-изохинолин-1-оны и 2, 3-дигидро-изоиндол-1-оны |